Osmanbeyoglu, H.U.; Palmer, D.; Sagan, A.; Sementino, E.; Becich, M.J.; Testa, J.R.
Isolated BAP1 Genomic Alteration in Malignant Pleural Mesothelioma Predicts Distinct Immunogenicity with Implications for Immunotherapeutic Response. Cancers 2022, 14, 5626.
https://doi.org/10.3390/cancers14225626
AMA Style
Osmanbeyoglu HU, Palmer D, Sagan A, Sementino E, Becich MJ, Testa JR.
Isolated BAP1 Genomic Alteration in Malignant Pleural Mesothelioma Predicts Distinct Immunogenicity with Implications for Immunotherapeutic Response. Cancers. 2022; 14(22):5626.
https://doi.org/10.3390/cancers14225626
Chicago/Turabian Style
Osmanbeyoglu, Hatice Ulku, Drake Palmer, April Sagan, Eleonora Sementino, Michael J. Becich, and Joseph R. Testa.
2022. "Isolated BAP1 Genomic Alteration in Malignant Pleural Mesothelioma Predicts Distinct Immunogenicity with Implications for Immunotherapeutic Response" Cancers 14, no. 22: 5626.
https://doi.org/10.3390/cancers14225626
APA Style
Osmanbeyoglu, H. U., Palmer, D., Sagan, A., Sementino, E., Becich, M. J., & Testa, J. R.
(2022). Isolated BAP1 Genomic Alteration in Malignant Pleural Mesothelioma Predicts Distinct Immunogenicity with Implications for Immunotherapeutic Response. Cancers, 14(22), 5626.
https://doi.org/10.3390/cancers14225626